Article Details

AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data

Retrieved on: 2025-04-22 12:36:11

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data. View article details on hiswai:

Excerpt

... monoclonal antibodies Herceptin and Perjeta—currently the standard of care in this indication. Without providing specific data, AstraZeneca and ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo